Back to GetFilings.com



Table of Contents

FORM 10-Q

 


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 1, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 0-18655

 


 

EXPONENT, INC.

(Exact name of registrant as specified in its charter)

 


 

DELAWARE   77-0218904

(State or other jurisdiction

of incorporation)

 

(I.R.S. Employer

Identification Number)

 

149 COMMONWEALTH DRIVE, MENLO PARK, CALIFORNIA   94025
(Address of principal executive office)   (Zip Code)

 

Registrant’s telephone number, including area code (650) 326-9400

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).    Yes  x    No  ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class


 

Outstanding at November 5, 2004


Common Stock $.001 par value

  7,974,809 shares

 



Table of Contents

EXPONENT, INC.

FORM 10-Q

 

TABLE OF CONTENTS

 

     Page

PART I – FINANCIAL INFORMATION

    

Item 1.

   Condensed Consolidated Financial Statements:     
          Condensed Consolidated Balance Sheets
October 1, 2004 and January 2, 2004
   3
          Condensed Consolidated Statements of Income
Three and Nine Months Ended October 1, 2004 and October 3, 2003
   4
          Condensed Consolidated Statements of Comprehensive Income
Three and Nine Months Ended October 1, 2004 and October 3, 2003
   5
          Condensed Consolidated Statements of Cash Flows
Nine Months Ended October 1, 2004 and October 3, 2003
   6
          Notes to Condensed Consolidated Financial Statements    7

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    14

Item 3.

   Quantitative and Qualitative Disclosure About Market Risk    23

Item 4.

   Controls and Procedures    24

PART II – OTHER INFORMATION

    

Item 6.

   Exhibits    24

Signatures

   25

 

- 2 -


Table of Contents

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

EXPONENT, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

October 1, 2004 and January 2, 2004

(in thousands, except share data)

(unaudited)

 

    

October 1,

2004


   

January 2,

2004


 
Assets                 

Current assets:

                

Cash and cash equivalents

   $ 11,224     $ 19,490  

Short-term investments

     31,434       22,268  

Accounts receivable, net of allowance for doubtful accounts of $1,631 and $1,248 at October 1, 2004 and January 2, 2004, respectively

     49,974       35,844  

Prepaid expenses and other assets

     3,912       2,095  

Deferred income taxes

     2,222       2,052  
    


 


Total current assets

     98,766       81,749  

Property, equipment and leasehold improvements, net

     30,215       30,793  

Goodwill

     8,607       8,607  

Other assets

     1,065       693  
    


 


     $ 138,653     $ 121,842  
    


 


Liabilities and Stockholders’ Equity                 

Current liabilities:

                

Accounts payable and accrued liabilities

   $ 4,062     $ 4,838  

Accrued payroll and employee benefits

     17,409       16,528  

Deferred revenues

     978       2,864  
    


 


Total current liabilities

     22,449       24,230  

Other liabilities

     860       169  

Deferred income taxes

     219       1,211  

Deferred rent

     1,083       1,031  
    


 


Total liabilities

     24,611       26,641  
    


 


Stockholders’ equity:

                

Common stock, $.001 par value; 20,000,000 shares authorized; 7,993,937 shares issued at October 1, 2004 and January 2, 2004, respectively

     8       8  

Additional paid-in capital

     38,797       34,153  

Deferred stock-based compensation

     (1,011 )     (69 )

Accumulated other comprehensive income

     9       94  

Retained earnings

     76,538       66,464  

Treasury stock, at cost, 57,574 and 694,988 shares held at October 1, 2004 and January 2, 2004, respectively

     (299 )     (5,449 )
    


 


Total stockholders’ equity

     114,042       95,201  
    


 


     $ 138,653     $ 121,842  
    


 


 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

- 3 -


Table of Contents

EXPONENT, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

For the Quarters and Nine Months Ended October 1, 2004 and October 3, 2003

(in thousands, except per share data)

(unaudited)

 

     Quarters Ended

   Nine Months Ended

     October 1,
2004


   October 3,
2003


   October 1,
2004


   October 3,
2003


Revenues:

                           

Revenues before reimbursements

   $ 35,170    $ 31,950    $ 106,669    $ 95,229

Reimbursements

     2,871      3,707      9,781      10,165
    

  

  

  

Revenues

     38,041      35,657      116,450      105,394

Operating expenses:

                           

Compensation and related expenses

     23,022      20,573      69,340      61,888

Other operating expenses

     4,690      4,383      13,917      13,434

Reimbursable expenses

     2,871      3,707      9,781      10,165

General and administrative expenses

     2,346      2,283      7,014      6,469
    

  

  

  

Total operating expenses

     32,929      30,946      100,052      91,956
    

  

  

  

Operating income

     5,112      4,711      16,398      13,438

Other income:

                           

Interest income, net

     110      35      299      59

Miscellaneous income, net

     156      128      377      478
    

  

  

  

Total other income

     266      163      676      537
    

  

  

  

Income before income taxes

     5,378      4,874      17,074      13,975

Income taxes

     2,205      2,026      7,000      5,984
    

  

  

  

Net income

   $ 3,173    $ 2,848    $ 10,074    $ 7,991
    

  

  

  

Net income per share:

                           

Basic

   $ 0.41    $ 0.39    $ 1.33    $ 1.11

Diluted

   $ 0.37    $ 0.36    $ 1.19    $ 1.01

Shares used in per share computations:

                           

Basic

     7,834      7,212      7,574      7,180

Diluted

     8,645      7,986      8,469      7,907

 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

- 4 -


Table of Contents

EXPONENT, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

For the Quarters and Nine Months Ended October 1, 2004 and October 3, 2003

(in thousands)

(unaudited)

 

     Quarters Ended

    Nine Months Ended

 
     October 1,
2004


    October 3,
2003


    October 1,
2004


    October 3,
2003


 

Net income

   $ 3,173     $ 2,848     $ 10,074     $ 7,991  

Other comprehensive income (loss):

                                

Foreign currency translation adjustments

     (15 )     3       (8 )     62  

Unrealized gain (loss) on investments

     11       (10 )     (77 )     (4 )
    


 


 


 


Comprehensive income

   $ 3,169     $ 2,841     $ 9,989     $ 8,049  
    


 


 


 


 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

- 5 -


Table of Contents

EXPONENT, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

For the Nine Months Ended October 1, 2004 and October 3, 2003

(in thousands)

(unaudited)

 

     Nine Months Ended

 
    

October 1,

2004


   

October 3,

2003


 

Cash flows from operating activities:

                

Net income

   $ 10,074     $ 7,991  

Adjustments to reconcile net income to net cash used in operating activities:

                

Depreciation and amortization

     3,010       2,538  

Deferred rent expense

     52       137  

Provision for doubtful accounts

     1,304       1,232  

Stock-based compensation

     192       69  

Deferred income tax provision

     (1,162 )     —    

Tax benefit for stock option plans

     2,722       —    

Changes in operating assets and liabilities:

                

Accounts receivable

     (15,434 )     (5,722 )

Prepaid expenses and other assets

     (1,972 )     1,288  

Accounts payable and accrued liabilities

     (781 )     207  

Accrued payroll and employee benefits

     1,865       246  

Deferred revenues

     (1,886 )     212  
    


 


Net cash (used in) provided by operating activities

     (2,016 )     8,198  
    


 


Cash flows from investing activities:

                

Purchases of short-term investments

     (19,567 )     (10,961 )

Sales and maturities of short-term investments

     9,917       —    

Capital expenditures

     (1,812 )     (1,773 )

Other assets

     296       (124 )
    


 


Net cash used in investing activities

     (11,166 )     (12,858 )
    


 


Cash flows from financing activities:

                

Repayments of borrowings and long-term obligations

     (50 )     (60 )

Repurchase of common stock

     —         (2,454 )

Proceeds from issuance of common stock

     4,954       1,907  
    


 


Net cash provided by (used in) financing activities

     4,904       (607 )
    


 


Effect of foreign currency exchange rates on cash and cash equivalents

     12       15  
    


 


Net decrease in cash and cash equivalents

     (8,266 )     (5,252 )

Cash and cash equivalents at beginning of period

     19,490       22,480